Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Vail

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Veterinary Internal Medicine|June 30, 2015
Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in DogsJ H Burton, R O Venable, D M Vail, et al.
Journal of the American Veterinary Medical Association|May 1, 1991
Efficacy of mitoxantrone against various neoplasms in dogsG K Ogilvie, J E Obradovich, R E Elmslie, et al.
Journal of Veterinary Internal Medicine|April 4, 2017
Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric LymphomaD H Thamm, D M Vail, G S Post, et al.
Journal of the American Animal Hospital Association|November 24, 1998
Prognosis for dogs with nonlymphomatous, small intestinal tumors treated by surgical excisionJ Crawshaw, J Berg, J C Sardinas, et al.
Cancer Biotherapy|January 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind studyL E Fox, E G MacEwen, I D Kurzman, et al.
Veterinary and Comparative Oncology|September 12, 2017
Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different dosesC F Saba, K R Vickery, C A Clifford, et al.
Journal of the American Veterinary Medical Association|May 1, 1991
Toxicoses associated with administration of mitoxantrone to dogs with malignant tumorsG K Ogilvie, J E Obradovich, R E Elmslie, et al.
Journal of the American Veterinary Medical Association|June 1, 1993
Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumorsG K Ogilvie, A S Moore, J E Obradovich, et al.
American Journal of Veterinary Research|July 15, 2000
Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinomaL E Fox, R C Rosenthal, R R King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trialD M Vail, E G MacEwen, I D Kurzman, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Veterinary Internal Medicine|June 30, 2015
Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in DogsJ H Burton, R O Venable, D M Vail, et al.
Journal of the American Veterinary Medical Association|May 1, 1991
Efficacy of mitoxantrone against various neoplasms in dogsG K Ogilvie, J E Obradovich, R E Elmslie, et al.
Journal of Veterinary Internal Medicine|April 4, 2017
Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric LymphomaD H Thamm, D M Vail, G S Post, et al.
Journal of the American Animal Hospital Association|November 24, 1998
Prognosis for dogs with nonlymphomatous, small intestinal tumors treated by surgical excisionJ Crawshaw, J Berg, J C Sardinas, et al.
Cancer Biotherapy|January 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind studyL E Fox, E G MacEwen, I D Kurzman, et al.
Veterinary and Comparative Oncology|September 12, 2017
Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different dosesC F Saba, K R Vickery, C A Clifford, et al.
Journal of the American Veterinary Medical Association|May 1, 1991
Toxicoses associated with administration of mitoxantrone to dogs with malignant tumorsG K Ogilvie, J E Obradovich, R E Elmslie, et al.
Journal of the American Veterinary Medical Association|June 1, 1993
Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumorsG K Ogilvie, A S Moore, J E Obradovich, et al.
American Journal of Veterinary Research|July 15, 2000
Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinomaL E Fox, R C Rosenthal, R R King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trialD M Vail, E G MacEwen, I D Kurzman, et al.
Pageof 8